TransMedics Group, Inc. — Director's Dealing 2022

Jul 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2022-07-05

Reporting Person: Gordon Stephen (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-05	Common Stock	M	10000	$2.21	Acquired	15714	Direct
2022-07-05	Common Stock	S	10000	$35.00	Disposed	5714	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-05	Stock Option (Right to Buy)	$2.21	M	10000	Disposed	2027-06-22	Common Stock (10000)	Direct

Footnotes

F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2: The option is fully vested.